Authors: Cardoso, F Ferreira, AF Crown, J Dolci, S Paesmans, M Riva, A Di Leo, A Piccart, MJ

Citation: F. Cardoso et al., Doxorubicin followed by docetaxel versus docetaxel followed by doxorubicinin the adjuvant treatment of node positive breast cancer: Results of a feasibility study, ANTICANC R, 21(1B), 2001, pp. 789-795

Authors: Schwartsmann, G Caldas, APF Dalla Costa, T Di Leone, L Campos, O Cancela, A Schunemann, H Ferreira, AF Sander, E Mans, DRA

Citation: G. Schwartsmann et al., Phase I study of three-times daily oral etoposide in patients with refractory solid tumours, CLIN DRUG I, 19(5), 2000, pp. 375-383

Authors: Schwartsmann, G Schunemann, H Gorini, CNF Ferreira, AF Garbino, C Sabini, G Muse, I DiLeone, L Mans, DR

Citation: G. Schwartsmann et al., A phase I trial of cisplatin plus decitabine, a new DNA-hypomethylating agent, in patients with advanced solid tumors and a follow-up early phase II evaluation in patients with inoperable non-small cell lung cancer, INV NEW DR, 18(1), 2000, pp. 83-91

Authors: Narula, SC Saldiva, PHN Andre, CDS Elian, SN Ferreira, AF Capelozzi, V

Citation: Sc. Narula et al., The minimum sum of absolute errors regression: A robust alternative to theleast squares regression, STAT MED, 18(11), 1999, pp. 1401-1417

Authors: de Arruda, M Souza, RC Veiga, ME Ferreira, AF Zimmerman, RH

Citation: M. De Arruda et al., Prevalence of Plasmodium vivax variants VK247 and P-vivax-like human malaria: a retrospective study in indigenous Indian populations of the Amazon region of Brazil, T RS TROP M, 92(6), 1998, pp. 628-628